VISTAGEN THERAPEUTICS ($VTGN) posted quarterly earnings results for Q4 2026 on Monday, June 15th. The company reported earnings of -$0.37 per share, missing estimates of -$0.34 by $0.03. The company also reported revenue of $470,000, beating estimates of $273,023 by $196,977.
You can see Quiver Quantitative's $VTGN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
VISTAGEN THERAPEUTICS Hedge Fund Activity
We have seen 26 institutional investors add shares of VISTAGEN THERAPEUTICS stock to their portfolio, and 40 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JANUS HENDERSON GROUP PLC removed 4,165,767 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $2,757,321
- NANTAHALA CAPITAL MANAGEMENT, LLC removed 1,978,492 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $1,309,563
- STEMPOINT CAPITAL LP removed 1,871,936 shares (-75.2%) from their portfolio in Q4 2025, for an estimated $1,239,034
- COMMODORE CAPITAL LP removed 1,575,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $1,042,492
- ACADIAN ASSET MANAGEMENT LLC added 589,663 shares (+inf%) to their portfolio in Q1 2026, for an estimated $336,992
- SOLEUS CAPITAL MANAGEMENT, L.P. removed 550,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $364,045
- TWO SIGMA INVESTMENTS, LP added 274,049 shares (+140.1%) to their portfolio in Q1 2026, for an estimated $156,619
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
